Abbott Agrees to Pay Over $384M to Settle Allegations Related to Contaminated Infant Formula
- DOJ: 1117 events in the last 90 days
- DOJ: 202th Legal in the last 90 days
- Previous: 1 days earlier · Federal grand jury indicts four in two related fraud schemes targeting elderly and vulnerable victims
What happened
Abbott Laboratories (Abbott), an Illinois-based healthcare company that manufactures and sells infant formula and nutritional therapy products, has agreed to pay $384,999,040 to resolve allegations that it caused false claims to be submitted between Jan. 1, 2018, and Dec. 31, 2022, to federal and state programs arising from its failure to manufacture certain powder infant
Summary assembled by rule from the sources below